SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000919574-09-003985
Filing Date
2009-02-25
Accepted
2009-02-25 16:24:28
Documents
1
Period of Report
2009-02-05

Document Format Files

Seq Description Document Type Size
1 p967226_ex.html 3/A  
1 p967226_ex.xml 3/A 5085
  Complete submission text file 0000919574-09-003985.txt   7501
Mailing Address 134 COOLIDGE AVE WATERTOWN MA 02472
Business Address 134 COOLIDGE AVE WATERTOWN MA 02472 617-926-1551
PANACOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001040017 (see all company filings)

IRS No.: 113238476 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 49 WEST 38TH STREET 11TH FLOOR NEW YORK NY 10018
Business Address 49 WEST 38TH STREET 11TH FLOOR NEW YORK NY 10018 212-332-7265
CONUS PARTNERS INC (Reporting) CIK: 0001174784 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-24241 | Film No.: 09634164

Mailing Address C/O CONUS PARTNERS, INC. 49 WEST 38TH STREET, 11TH FLOOR NEW YORK NY 10018
Business Address 212-332-7265
ZACKS ANDREW (Reporting) CIK: 0001437688 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-24241 | Film No.: 09634163